We aim to make Greater Manchester one of the most innovative health and social care systems around the world. Health Innovation Manchester works with innovators to discover, develop and deploy new solutions that improve the health and wellbeing of Greater Manchester’s 2.8m citizens.
Our work portfolio can be described under four main categories. Click on each to read more about our innovation projects.
Working with our partners, we’re unlocking the full potential of digital technology through a range of digital health and care projects, real world evidence studies and use of data science techniques. This is underpinned by collaboration with patients, citizens, professionals and industry to drive forward digital transformation together and improve the standard and quality of care for our citizens.
We have an active portfolio of innovation projects that are being deployed across Greater Manchester to help improve local people’s health and wellbeing. These include using new technology and devices, digital products and tools, optimising medication and modifying practice.
Projects span all aspects of health and care including maternity, cardiovascular, cancer, respiratory, mental health and frailty, as well as cross cutting themes such as patient safety, medicines and precision health.
We have a proven track record in fostering industry partnerships to deliver population health improvements, from start-ups to global players. The benefits of devolution, combined with the strength of our commercial life sciences sector and assets in health tech, data analysis and healthcare put us in a fantastic position to accelerate innovation that will improve health outcomes for our citizens.
We have a thriving programme of research activities across the six domains of research excellence – cancer, cardiovascular disease, inflammation and repair, women and children, mental health, and neuroscience.
We are working with local research partners to focus activity on addressing the health and social care priorities, as well as to secure further funding and advance translational research delivery into the frontline.